RESUMO
Central giant cell granuloma (CGCG) is a benign but locally aggressive intraosseous lesion of the mandible. Historically, it is treated by curettage or resection. Medical therapy is indicated when surgery is associated with increased morbidity or in adjuvant setting to decrease recurrence. Treatment of CGCG with denosumab, a receptor activator of nuclear factor kappa-beta (RANK) ligand inhibitor, is not well studied, especially in children. Here, we describe our experience with the use of denosumab in the treatment of six children with CGCG. All patients had a favorable response with manageable side effects, which suggests that denosumab is an effective treatment option without increased morbidity.
Assuntos
Conservadores da Densidade Óssea/uso terapêutico , Denosumab/uso terapêutico , Granuloma de Células Gigantes/tratamento farmacológico , Criança , Pré-Escolar , Feminino , Seguimentos , Granuloma de Células Gigantes/patologia , Humanos , Masculino , PrognósticoAssuntos
Antineoplásicos/uso terapêutico , Tumor Desmoplásico de Pequenas Células Redondas/tratamento farmacológico , Embolização Terapêutica/métodos , Hiperesplenismo/terapia , Trombocitopenia/terapia , Criança , Ciclofosfamida/uso terapêutico , Doxorrubicina/uso terapêutico , Etoposídeo/uso terapêutico , Feminino , Humanos , Ifosfamida/uso terapêutico , Vincristina/uso terapêuticoAssuntos
Imidazóis/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Piridazinas/uso terapêutico , Adolescente , Feminino , Humanos , Imidazóis/farmacologia , Mutação , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologia , Piridazinas/farmacologia , RecidivaRESUMO
Cefepime is increasingly used as empiric treatment for fever in the setting of neutropenia. We present a patient with acute-on-chronic renal disease who received cefepime at the appropriate dose for his glomerular filtration rate but developed cefepime-associated encephalopathy. Here, we review neurologic toxicities of cefepime and present suggestions for work-up and management.